Countries Europe

Chromatin Bioscience Partners with Astellas to Advance Cell-Selective Gene Expression Technologies

Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with As...

 April 15, 2025 | News

Seegene to Introduce Vision for Fully Automated PCR Testing with CURECA™ at ESCMID Global 2025 in Vienna

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected ...

 April 10, 2025 | News

Lunit Study Reveals Trust Gap Between Radiologists and AI in Real-World Breast Cancer Screening in Sweden

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study i...

 April 10, 2025 | Report

Logistics4Pharma Expands Customs Services to Strengthen Global Pharma Supply Chains

 Logistics4Pharma, a Frankfurt-based GDP-certified pharma logistics provider, has expanded its service portfolio. In addition to Temporary Storage und...

 April 09, 2025 | News

Bayer Seeks U.S. Supreme Court Intervention in Missouri Roundup™ Case Amid Nationwide Labeling Disputes

Bayer – through its indirect subsidiary Monsanto – filed its petition for a writ of certiorari with the U.S. Supreme Court in the&nbs...

 April 07, 2025 | News

Cytiva Introduces MabSelect SuRe 70 & PrismA X to Boost Cost-Efficient mAb Purification

MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability  and productivity  Cytiva's expanded resin portfolio wil...

 April 04, 2025 | News

IRBM Launches Advanced Functional Genomics Platform to Power Precision Target Discovery and Validation

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Pl...

 April 03, 2025 | News

SHL Medical Launches $220M Autoinjector Facility in South Carolina to Boost US Production and Global Supply

SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-o...

 April 02, 2025 | News

Henlius and Organon’s HLX11 Biosimilar of Pertuzumab Accepted for Review by European Medicines Agency

Shanghai Henlius Biotech, Inc. and Organon   announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Appli...

 March 31, 2025 | News

KELES and PwC Set Benchmark with First SFDR Article 9 ESG Framework for Digital Health VC

PwC and KELES, the pioneering digital health venture capital (VC) firm, are setting a new standard in digital health investment, leveraging ESG and innovat...

 March 28, 2025 | News

Vaximm Reports Promising Final Data from Phase 2a Trial of Oral Vaccine VXM01 with Avelumab in Recurrent Glioblastoma

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies,  announced fina...

 March 27, 2025 | News

Thermo Fisher Scientific Launches IVDR-Compliant SeqStudio™ Flex Dx to Elevate Clinical Lab Performance

— Thermo Fisher Scientific, the world leader in serving science, has announced the launch of the Applied Biosystems™ SeqStudio™ Flex Dx G...

 March 26, 2025 | News

CStone Submits EMA Application to Expand Sugemalimab Use in Stage III Lung Cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies,  announced the submiss...

 March 25, 2025 | News

Menarini Group, Stemline, and VisualDx Join Forces to Boost Early Detection of BPDCN Using AI-Driven Skin Imaging

BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 ...

 March 21, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close